advances in the prevention and treatment of … · 2011-02-16 · 1:00 pm case presentation 1:05 pm...

2
EXCEL CONTINUING EDUCATION 7990 SW 64 STREET MIAMI, FL 33143 GUEST FACULTY Clifford Rosen MD, Senior Scientist Maine Medical Center Research Institute Bangor, Maine Eric Orwoll, MD, Professor of Medicine Oregon Health and Science University Portland, Oregon Michael Liewicki, MD New Mexico Clinical Research & Osteoporosis Center Albuquerque, NM John Kanis, MD, Professor Emeritus University of Sheffield Sheffield, UK EDUCATIONAL OBJECTIVES At, the conclusion of this conference you should be able to: -- Explain the underlying pathogenesis for fracture risk in obesity and diabetes mellitus and how to reduce this risk in your patients. -- Review the etiologies and treatment of male osteoporosis and how MrOS has assisted us in understanding the differences in fracture risk between men and women. -- Discuss the clinical utility of FDA-approved osteoporosis therapies and the impact of these therapies on your patients. -- Review the clinical utility of FRAX in different ethnicities in the United States and clarifications of the algorithm since the 2010 ISCD-IOF FRAX Initiative. ADVANCES IN THE PREVENTION AND TREATMENT OF OSTEOPOROSIS 2011 THURSDAY APRIL 7, 2011 Clinical Research Building Gordon Center Auditorium 1 st Floor 1120 NW 14th Street Miami, FL 33136 AN ACCREDITED CME SYMPOSIUM Sanford Baim, MD Division of Endocrinology Medical Symposium Director *********** In collaboration with 17 th Annual Meeting April 6-9, 2011 Intercontinental Hotel Miami, Florida

Upload: others

Post on 10-Aug-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: ADVANCES IN THE PREVENTION AND TREATMENT OF … · 2011-02-16 · 1:00 PM Case presentation 1:05 PM Diabetes, Obesity, High BMI Predisposes to Osteoporotic Fracture: What’s New

EXCEL CONTINUING

EDUCATION

7990 SW 64 STREET

MIAMI, FL 33143

GUEST FACULTY

Clifford Rosen MD, Senior Scientist

Maine Medical Center Research Institute

Bangor, Maine

Eric Orwoll, MD, Professor of Medicine

Oregon Health and Science University

Portland, Oregon

Michael Liewicki, MD

New Mexico Clinical Research & Osteoporosis

Center

Albuquerque, NM

John Kanis, MD, Professor Emeritus

University of Sheffield

Sheffield, UK

EDUCATIONAL OBJECTIVES

At, the conclusion of this conference you should

be able to:

-- Explain the underlying pathogenesis for

fracture risk in obesity and diabetes mellitus and

how to reduce this risk in your patients.

-- Review the etiologies and treatment of male

osteoporosis and how MrOS has assisted us in

understanding the differences in fracture risk

between men and women.

-- Discuss the clinical utility of FDA-approved

osteoporosis therapies and the impact of these

therapies on your patients.

-- Review the clinical utility of FRAX in different

ethnicities in the United States and clarifications of

the algorithm since the 2010 ISCD-IOF FRAX

Initiative.

ADVANCES IN THE

PREVENTION AND

TREATMENT OF

OSTEOPOROSIS 2011

THURSDAY

APRIL 7, 2011

Clinical Research Building

Gordon Center Auditorium

1st Floor

1120 NW 14th Street

Miami, FL 33136

AN ACCREDITED CME

SYMPOSIUM

Sanford Baim, MD

Division of Endocrinology

Medical Symposium

Director

***********

In collaboration with

17th Annual Meeting

April 6-9, 2011

Intercontinental Hotel Miami, Florida

Page 2: ADVANCES IN THE PREVENTION AND TREATMENT OF … · 2011-02-16 · 1:00 PM Case presentation 1:05 PM Diabetes, Obesity, High BMI Predisposes to Osteoporotic Fracture: What’s New

PROGRAM AGENDA

11:45 AM Registration and Lunch

12:45 PM Introduction of Dean Pascal

Goldschmidt by Dr. Antonio

Bianco, Chief of the Division of

Endocrinology

12:50 PM Symposium Overview by Dr.

Sanford Baim

12:55 PM Speaker Disclosures and

Sponsor Acknowledgements

1:00 PM Case presentation

1:05 PM Diabetes, Obesity, High BMI

Predisposes to Osteoporotic

Fracture: What’s New

between Bone and Fat?

Clifford Rosen, MD

1:45 PM Open discussion

2:00 PM Case presentation

2:05 PM Male Osteoporosis and MrOS

Eric Orwoll, MD

2:45 PM Open discussion

3:00 PM Break

3:15 PM Case presentation

3:20 PM Benefits and Treatment for

Postmenopausal

Osteoporosis

Michael Liewicki, MD

4:00 PM Open discussion

4:15 PM Case presentation

4:20 PM Prediction of Fractures

Using Absolute Fracture Risk

and the 2010 ISCD-IOF FRAX Initiative

John Kanis, MD

5:00 PM Open discussion

5:15 PM Closing remarks

Sanford Baim, MD

5:20 PM Adjourn

TARGET AUDIENCE AND

SYMPOSIUM GOAL

This educational activity is designed for practicing Endocrinologists, Internal Medicine Physicians, Physician Assistants, Nurse Practitioners, Nurses, Fellows, Residents and other HCPs who want to update their knowledge regarding the latest developments in managing and treating osteoporosis and the contributing factors that lead to osteoporotic risk fractures in order to improve patient care.

ACCREDITATION AND CREDITS

EXCEL Continuing Education is accredited by the ACCME to provide continuing medical education for physicians. EXCEL Continuing Education designates this live activity for a maximum of four AMA PRA Category 1 Credits™. Physicians should claim credit commensurate with the extent of their participation in the activity. Physician Assistants and Nurse Practitioners: AAPA and AANP accept AMA Category 1 Credit from organizations accredited by the ACCME.

FACULTY DISCLOSURE

In accordance with ACCME guidelines, any discussions of unlabeled unapproved uses of drugs or devices will be disclosed to the audience. Full disclosure will be made in the course materials and verbally disclosed prior to the start of the live educational activity.

ADVANCES IN THE PREVENTION AND

TREATMENT OF OSTEOPOROSIS IN 2011

REGISTRATION FORM

THURSDAY, APRIL 7, 2011

REGISTRATION: 11:45 AM

SCIENTIFIC SESSIONS: 12:45 PM

Clinical Research Building

Gordon Center Auditorium - 1st Floor

1120 NW 14th Street - Miami, FL

PARKING is available right next to the

building on the west side. ________________________________________

ACKNOWLEDGEMENTS

This activity is supported through educational

grants from:

AMGEN

LILLY USA MERCK SHARP & DOHME

LAST NAME

FIRST NAME

DEGREE _ MD, DO _ NP, RN _ PA

_ OTHER

ADDRESS

CITY, STATE

PHONE #

FAX #

EMAIL

REGISTRATION: Complimentary. You will

receive a confirmation number either by fax

or email. You may either:

* Register on line at

www.excelcmeconferences.com

* Fax the completed form to: 786-263-0956

* Send this form to EXCEL Continuing

Education, 7990 SW 64 Street, Miami, FL

33143

* For info, call 305-630-9414

THERE IS NO CHARGE FOR REGISTRATION

This registration form may be photocopied

for your colleagues.